|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/04 | (2006.01) |
| C07D 401/04 | (2013.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 31/12 | (2018.01) | ||
| A61P 37/00 | (2018.01) | ||
| A61P 37/06 | (2018.01) |
| (11) | Number of the document | 3466942 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18206764.5 |
| Date of filing the European patent application | 2013-08-08 | |
| (97) | Date of publication of the European application | 2019-04-10 |
| (45) | Date of publication and mention of the grant of the patent | 2022-04-20 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261681477 P | 2012-08-09 | US |
| (72) |
TRAVERSE, John Fitzgerald , US
ZHANG, Chengmin , US
FEIGELSON, Gregg B. , US
COHEN, Benjamin M. , US
LEONG, William Wei-Hwa , US
|
| (73) |
Celgene Corporation ,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | PROCESSES FOR THE PREPARATION OF (S)-3-4-((4-(MORPHOLINOMETHYL) BENZYL)OXY)-1-OXOISOINDOLIN-2-YL) PIPERIDINE-2,6-DIONE AND PHARMACEUTICALLY ACCEPTABLE FORMS THEREOF |
| PROCESSES FOR THE PREPARATION OF (S)-3-4-((4-(MORPHOLINOMETHYL) BENZYL)OXY)-1-OXOISOINDOLIN-2-YL) PIPERIDINE-2,6-DIONE AND PHARMACEUTICALLY ACCEPTABLE FORMS THEREOF |